R&D, Leadership Development Associate
Legend Biotech US
Summary
We are seeking an initiative-taking and creative scientist to grow our pipeline efforts. The candidate will be an integral part of our Philadelphia R&D team, whose aim is to research, develop and advance the next generation of in vivo cell therapies and create novel CAR therapy to treat a wide range of cancer and autoimmune diseases. Expertise in immunology and/or oncology is required. As part of the Legend Biotech R&D team and under minimal supervision, you will be responsible for timely execution and delivery of projects in our discovery pipeline.
Job description
Role Overview
We are seeking an initiative-taking and creative scientist to grow our pipeline efforts. The candidate will be an integral part of our Philadelphia R&D team, whose aim is to research, develop and advance the next generation of in vivo cell therapies and create novel CAR therapy to treat a wide range of cancer and autoimmune diseases. Expertise in immunology and/or oncology is required. As part of the Legend Biotech R&D team and under minimal supervision, you will be responsible for timely execution and delivery of projects in our discovery pipeline.
Key Responsibilities
- Lead, design and optimize research of next generation in vivo CAR-T cell therapies.
- Lead and contribute to project creation through dissection of published literature to find novel solutions to in-vivo cell therapy problems.
- Isolate immune cells from leukopak or blood of healthy donors or patients and execute the evaluation of in-vivo CAR virus using a battery of in-vitro assays and in-vivo mice models.
- Perform solid tumor research using a variety of techniques including 2D & 3D cell culture, transfection, FACS, and cell-based functional assays.
- Package and titer engineered viruses to infect immune cells in vitro and in vivo; characterize virus particles with protein and PCR based assays; measure transduction rate using flow and VCN analysis.
- Generate, manage, evaluate, and maintain critical data in a highly organized manner, including the use of ELN.
- Deliver results to meet timeline with accountability through presentation to a wide range of audiences of internal group meetings and other forums.
- Establish and maintain good collaborations with teammates and across the R&D organization.
- Maintain compliance with GLP and EHS protocols.
Requirements
- PhD in Immunology or related discipline
- 2 years of experience in the field of cell and gene therapy
- Extensive experience in immune cell-based analytics and assay development including advanced multi-parameter flow-cytometry, cytotoxicity assay, cytokine release ELISA/MSD multiplex assays
- Experience with lentivirus particle characterization and quantification using molecular (VCN) and flow-based assays
- Track record of productivity evidenced by publications or patents
- Familiarity with AI tools such as Microsoft Copilot, ChatGPT, or Gemini
- Be able to work independently to plan and timely execute research projects
- Proficient in advanced gene delivery methods using LVV, VLP or LNP technologies
- Strong experience with lentivirus production, tittering and transduction
- Working molecular biology and cellular biology knowledge in design and evaluation of modified viral vectors
- Strong multitasking, problem-solving and collaborative skills
- Excellent verbal and written communication skills
- Must be authorized to work in the United States
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Paid Parental Leave
- Paid Time Off
- Floating Holidays
- Company Holidays
- Flexible Spending Account
- Health Savings Account
- Life & AD&D Insurance
- Short & Long-Term Disability
- Legal Assistance
- Pet Insurance
- Critical Illness Insurance
- Accident Insurance
- Hospital Indemnity Insurance
- Commuter Benefits
- Family Planning Resources
- Well-being Initiatives
- Performance Bonus
- Equity
Company overview
Legend Biotech is a global, commercial-stage biotechnology company specializing in the development and manufacturing of advanced cell therapies. Headquartered in Somerset, New Jersey, the company was founded in 2014 and has grown to become a leader in the cell therapy space with over 2,600 employees worldwide. Legend Biotech focuses on innovative cellular immunotherapy platforms, including autologous and allogeneic chimeric antigen receptor T-cell (CAR-T) therapies, natural killer (NK) cell-based immunotherapies, and non-gene-editing universal CAR-T technologies. The company's flagship product, CARVYKTI® (ciltacabtagene autoleucel), developed in collaboration with Johnson & Johnson, is a BCMA-directed CAR-T therapy approved for the treatment of relapsed or refractory multiple myeloma. With a robust pipeline of 11 investigational therapies spanning multiple disease areas, Legend Biotech operates research and development facilities across the United States, Europe, and China, maintaining a strong commitment to transforming patient care through cutting-edge cellular therapies.